These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12086727)

  • 21. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
    Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
    Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpolymer Complexation Between Polyox and Carbopol, and Its Effect on Drug Release From Matrix Tablets.
    Zhang F; Lubach J; Na W; Momin S
    J Pharm Sci; 2016 Aug; 105(8):2386-96. PubMed ID: 27353208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pectinolytic enzymes on the theophylline release from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate.
    Semdé R; Amighi K; Devleeschouwer MJ; Moës AJ
    Int J Pharm; 2000 Mar; 197(1-2):169-79. PubMed ID: 10704804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the Efficacy of Poly(N-isopropylacrylamide) for Drug Delivery Applications Using Molecular Dynamics Simulations.
    Moghadam S; Larson RG
    Mol Pharm; 2017 Feb; 14(2):478-491. PubMed ID: 28026965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermo-sensitive poly(N-isopropylacrylamide)/ mesoporous silica nanocomposites as controlled delivery carriers: loading and release behaviors for drug ibuprofen.
    Tian BS; Yang C
    J Nanosci Nanotechnol; 2011 Mar; 11(3):1871-9. PubMed ID: 21449323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices.
    Shojaee S; Emami P; Mahmood A; Rowaiye Y; Dukulay A; Kaialy W; Cumming I; Nokhodchi A
    AAPS PharmSciTech; 2015 Dec; 16(6):1281-9. PubMed ID: 25771738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fast-responsive porous thermoresponsive microspheres for controlled delivery of macromolecules.
    Fundueanu G; Constantin M; Ascenzi P
    Int J Pharm; 2009 Sep; 379(1):9-17. PubMed ID: 19505547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xanthan gum as a rate-controlling polymer for the development of alcohol resistant matrix tablets and mini-tablets.
    Lazzari A; Kleinebudde P; Knop K
    Int J Pharm; 2018 Jan; 536(1):440-449. PubMed ID: 29225098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties and mechanisms of drug release from matrix tablets containing poly(ethylene oxide) and poly(acrylic acid) as release retardants.
    Zhang F; Meng F; Lubach J; Koleng J; Watson NA
    Eur J Pharm Biopharm; 2016 Aug; 105():97-105. PubMed ID: 27260202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets.
    Barreiro-Iglesias R; Bromberg L; Temchenko M; Hatton TA; Alvarez-Lorenzo C; Concheiro A
    Eur J Pharm Sci; 2005 Dec; 26(5):374-85. PubMed ID: 16165345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and characterization of thermoresponsive copolymers for drug delivery.
    Aerry S; De A; Kumar A; Saxena A; Majumdar DK; Mozumdar S
    J Biomed Mater Res A; 2013 Jul; 101(7):2015-26. PubMed ID: 23255175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential intracellular release of water-soluble cargos from Shell-crosslinked polymersomes.
    Du F; Bobbala S; Yi S; Scott EA
    J Control Release; 2018 Jul; 282():90-100. PubMed ID: 29601932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization and controlled drug release of thermosensitive IPN-PNIPAAm hydrogels.
    Zhang XZ; Wu DQ; Chu CC
    Biomaterials; 2004 Aug; 25(17):3793-805. PubMed ID: 15020155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
    Wulff R; Leopold CS
    Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.